Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells

Fig. 5

Expected and observed relaxant response induced by low concentrations (EC30) of glycopyrronium, indacaterol and forskolin administered as double (a) or triple (b) combinations in human isolated bronchi submaximally pre-contracted with acetylcholine (EC70), as predicted by the Bliss Independence theory. c Influence of low concentrations (EC30) of glycopyrronium, indacaterol and forskolin administered as double and triple combinations on the delta effect between observed and expected cAMP concentrations in human isolated bronchi submaximally pre-contracted with acetylcholine (EC70), as predicted by the Bliss Independence theory. d Correlation between the cAMP concentrations induced by glycopyrronium, indacaterol and forskolin combinations and relaxant response of human isolated airways submaximally pre-contracted with acetylcholine (EC70). Data are expressed as mean ± SEM from experiments performed using samples from n = 3 different subjects. *P < 0.05 vs. expected additive effect as predicted by Bliss Independence equations (statistical significance assessed by t test analysis). cAMP: cyclic adenosine monophosphate; EC70: dose inducing 70 % maximal effect; Emax: maximal effect; EP+: epithelium intact; EP−: epithelium denuded; FSK: forskolin; GLY: glycopyrronium bromide; IND: indacaterol fumarate

Back to article page